TH169401A - Hydroxyformamide derivatives and their use - Google Patents
Hydroxyformamide derivatives and their useInfo
- Publication number
- TH169401A TH169401A TH1601004031A TH1601004031A TH169401A TH 169401 A TH169401 A TH 169401A TH 1601004031 A TH1601004031 A TH 1601004031A TH 1601004031 A TH1601004031 A TH 1601004031A TH 169401 A TH169401 A TH 169401A
- Authority
- TH
- Thailand
- Prior art keywords
- tll1
- bmp1
- tll2
- revealed
- compounds
- Prior art date
Links
- KDGKTJGPFXIBEB-UHFFFAOYSA-N N-hydroxyformamide Chemical class ONC=O KDGKTJGPFXIBEB-UHFFFAOYSA-N 0.000 title 1
- 108090000654 Bone Morphogenetic Protein 1 Proteins 0.000 claims abstract 8
- 102000004152 Bone Morphogenetic Protein 1 Human genes 0.000 claims abstract 8
- 102100009621 TLL1 Human genes 0.000 claims abstract 8
- 101700038999 TLL1 Proteins 0.000 claims abstract 8
- 102100009620 TLL2 Human genes 0.000 claims abstract 8
- 101700040031 TLL2 Proteins 0.000 claims abstract 8
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 230000000694 effects Effects 0.000 claims abstract 4
- 239000003112 inhibitor Substances 0.000 claims abstract 4
- 230000002401 inhibitory effect Effects 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Abstract
แก้ไขบทสรุปการประดิษฐ์ 11/08/59 สิ่งที่ถูกเปิดเผยเป็นสารประกอบที่มีสูตร (สูตรเคมี) ที่ซึ่ง R1, R2 และ R3 ตามที่กำหนดไว้ในที่นี้, และวิธีการของการทำและการใช้เดียวกัน, รวมถึงการใช้เป็นสารยับยั้งของ BMP1, TLL1 และ/หรือ TLL2 และในการบำบัดโรคที่เกี่ยวของกับ กิจกรรม BMP1, TLL1 และ/หรือ TLL2 --------------------------------------------------------------------- สิ่งที่ถูกเปิดเผยเป็นสารประกอบที่มีสูตร: (สูตรเคมี) ที่ซึ่ง R1, R2 และ R3 ตามที่กำหนดไว้ในที่นี้, และวิธีการของการทำและการใช้เดียวกัน, รวมถึงการใช้เป็นสารยับยั้งของ BMP1, TLL1 และ/หรือ TLL2 และในการบำบัดโรคที่เกี่ยวของกับ กิจกรรม BMP1, TLL1 และ/หรือ TLL2: สิทธิบัตรยา Revised Invention Summary 11/08/16 What is revealed are compounds with formulas (chemical formulas) where R1, R2 and R3 are defined here, and methods of making and using the same, including Use as a inhibitor of BMP1, TLL1 and / or TLL2 and in the treatment of diseases related to BMP1, TLL1 and / or TLL2 activity -------------------- ------------------------------------------------- Things Revealed are compounds with the formula: (chemical formula) where R1, R2 and R3 are defined here, and the same methods of making and use, including their use as inhibitors of BMP1, TLL1 and / Or TLL2 and in the therapy of activity-related BMP1, TLL1 and / or TLL2: drug patents
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH169401A true TH169401A (en) | 2017-10-19 |
| TH169401B TH169401B (en) | 2017-10-19 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2016000298A (en) | PIRAZOLOPIRIDINAS AND PIRAZOLOPIRIMIDINAS | |
| UY32123A (en) | DERIVATIVES OF N - (REPLACED) - 4 - (BUT-2-INILOXI) - BENZAMIDA, ITS RACEMATS, DIASTEREÒMEROS, ENANTIÒMEROS AND SALTS OF THE SAME AND APPLICATIONS | |
| DOP2016000109A (en) | SOLID FORMS OF ACID {[5- (3-CHLOROPHENYL) -3-HYDROXIPIRIDIN-2-CARBON] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME. | |
| UY35821A (en) | HETEROCYCLIC COMPOUND | |
| UA116648C2 (en) | FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES | |
| UY30846A1 (en) | OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES | |
| DOP2009000165A (en) | DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES | |
| CL2019000476A1 (en) | Heteroarylcarboxamide compounds as ripk2 inhibitors. | |
| EA201691412A1 (en) | HYDROXYFORMAMIDE DERIVATIVES AND THEIR APPLICATION | |
| BR112017006264A2 (en) | 4'-vinyl-substituted nucleoside derivatives as respiratory syncytial virus RNA replication inhibitors | |
| CL2019002480A1 (en) | Pyrazole derivatives as bromodomain inhibitors. | |
| HN2011000404A (en) | ENFUMAFUNGINA AND COMPOSITION DERIVATIVES UNDERSTANDING THE SAME | |
| EA201990313A1 (en) | DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR | |
| TH169401A (en) | Hydroxyformamide derivatives and their use | |
| TH169401B (en) | Hydroxyformamide derivatives and their use | |
| TH1901002344A (en) | Novel naphthyridone derivatives and their use in the treatment of cardiac arrhythmias. | |
| TH168624A (en) | Glucopyranosil-substrate derivatives Indole-urea And the use of those substances As an SGLT inhibitor | |
| TH163132A (en) | A benzylamine derivative that is a plasma calicrene inhibitor. | |
| TH176363A (en) | Sulfonamides that are modified substances of sodium channel. | |
| TH156856A (en) | Benzodiazole derivatives And how to prepare And the use of such substances | |
| TH1801004949A (en) | new condensed pirimidine compounds or their salts | |
| TH170181A (en) | New useful methyl-piperidine compound to inhibit microsomal Prostaglandin E2 Synthes-1 | |
| TH1701002063A (en) | Aldosteron Synthes inhibitors | |
| TH173507A (en) | Welded-loop derivatives of dihydropyrimidoes as HBV inhibitors | |
| TH169353A (en) | Acetidinyl oxychophenyl perrolidine compound |